These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 9040010

  • 1. Definition of an extended MHC class II-peptide binding motif for the autoimmune disease-associated Lewis rat RT1.BL molecule.
    Wauben MH, van der Kraan M, Grosfeld-Stulemeyer MC, Joosten I.
    Int Immunol; 1997 Feb; 9(2):281-90. PubMed ID: 9040010
    [Abstract] [Full Text] [Related]

  • 2. MHC class II-regulated central nervous system autoaggression and T cell responses in peripheral lymphoid tissues are dissociated in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.
    Weissert R, de Graaf KL, Storch MK, Barth S, Linington C, Lassmann H, Olsson T.
    J Immunol; 2001 Jun 15; 166(12):7588-99. PubMed ID: 11390515
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Direct binding of autoimmune disease related T cell epitopes to purified Lewis rat MHC class II molecules.
    Joosten I, Wauben MH, Holewijn MC, Reske K, Pedersen LO, Roosenboom CF, Hensen EJ, van Eden W, Buus S.
    Int Immunol; 1994 May 15; 6(5):751-9. PubMed ID: 7521668
    [Abstract] [Full Text] [Related]

  • 5. The peptide binding specificity of the MHC class II I-A molecule of the Lewis rat, RT1.BI.
    Reizis B, Mor F, Eisenstein M, Schild H, Stefanoviç S, Rammensee HG, Cohen IR.
    Int Immunol; 1996 Dec 15; 8(12):1825-32. PubMed ID: 8982766
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A peptide binding motif for I-Eg7, the MHC class II molecule that protects E alpha-transgenic nonobese diabetic mice from autoimmune diabetes.
    Gregori S, Trembleau S, Penna G, Gallazzi F, Hammer J, Papadopoulos GK, Adorini L.
    J Immunol; 1999 Jun 01; 162(11):6630-40. PubMed ID: 10352280
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. MHC class II isotype- and allele-specific attenuation of experimental autoimmune encephalomyelitis.
    de Graaf KL, Barth S, Herrmann MM, Storch MK, Otto C, Olsson T, Melms A, Jung G, Wiesmüller KH, Weissert R.
    J Immunol; 2004 Aug 15; 173(4):2792-802. PubMed ID: 15294998
    [Abstract] [Full Text] [Related]

  • 15. Superantigen-presentation by rat major histocompatibility complex class II molecules RT1.Bl and RT1.Dl.
    Dlaske H, Karaüzüm H, Monzon-Casanova E, Rudolf R, Starick L, Müller I, Wildner G, Diedrichs-Möhring M, Koch N, Miyoshi-Akiyama T, Uchiyama T, Wonigeit K, Fleischer B, Overbeck S, Rink L, Herrmann T.
    Immunology; 2009 Sep 15; 128(1 Suppl):e572-81. PubMed ID: 19740318
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Helper T cell epitope-mapping reveals MHC-peptide binding affinities that correlate with T helper cell responses to pneumococcal surface protein A.
    Singh R, Singh S, Sharma PK, Singh UP, Briles DE, Hollingshead SK, Lillard JW.
    PLoS One; 2010 Feb 25; 5(2):e9432. PubMed ID: 20195541
    [Abstract] [Full Text] [Related]

  • 19. Allogeneic core amino acids of an immunodominant allopeptide are important for MHC binding and TCR recognition.
    Sitaru AG, Timmermann W, Ulrichs K, Otto C.
    Hum Immunol; 2004 Aug 25; 65(8):817-25. PubMed ID: 15336783
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of experimental autoimmune encephalomyelitis by MHC class II binding competitor peptides depends on the relative MHC binding affinity of the disease-inducing peptide.
    Wauben MH, Joosten I, Schlief A, van der Zee R, Boog CJ, van Eden W.
    J Immunol; 1994 Apr 15; 152(8):4211-20. PubMed ID: 7511673
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.